March 20, 2017 OUTPERFORM

COMPANY RESEARCH | Company Update

Bangkok Chain Hospital

(BCH TB)
Share Price: Bt13.1 Target Price: Bt16.5 (+26.0%)

A new lease of life

WMC to turn positive EBITDA in FY17F driven by higher number
of Thai patients after launching a marketing campaign

Expect earnings to grow 20% yoy to Bt902m in FY17F thanks to
larger SS member base and smaller losses at WMC

Maintain OUTPERFORM rating with lower DCF-based TP of
Bt16.5/sh (from Bt18/sh), implying 22x FY17F EV/EBITDA
Attracting more Thai patients to offset slower growth of
international patient volume at WMC
The management team led by Chairman and CEO Dr. Chalerm hosted
the analyst briefing last Friday. World Medical Center (WMC) has
changed its name to World Medical Hospital and will focus more on Thai Teerapol UDOMVEJ
patients. Management expect Thai patient revenue to double this year
662 - 659 7000 ext 5012
driven by the new marketing campaign, The best job in Thailand. BCH
teerapol.udomvej@krungsrisecurities.com
will recruit a surveyor of patient happiness at WMC for a salary of
Bt1.0m/month for 6-month periods. This is a viral marketing strategy
aimed at building brand awareness among Thais. WMC will also offer Key Data
free service consultation to Thai patients on first visit. More importantly, 12-mth high/low (Bt) 16.10 / 9.95
this new strategy is meant to offset the falling international patient Market capital (Btm/US$m) 32,668.1 / 925.1
3m avg. turnover (Btm/US$m) 158.7 / 4.5
revenue in 4Q16 and 1Q17. We forecast WMC will turn positive EBITDA
Free float (%) 37.7
and book a smaller loss of Bt131m in FY17F (vs Bt172m loss in FY16).
Issued shares (m shares) 2,494
Additional SS revenues from health check services Major shareholders:
Hospitals under Kasemrad (KH) and Karunvej (KV) should continue to - HARNPHANICH CHALERM 32.6
deliver strong earnings this year. Its Social Security (SS) quota has - HARNPHANICH SOMPORN 7.4
- THAI NVDR CO LTD 5.1
been increased by 14% to 1.16m this year. The Social Security Office
has also said SS members would get free health checks starting 2017.
Share Price Performance
Participating hospitals would be paid c.Bt500/patient. This will boost
both revenues and margins because health checks command higher
margins than other treatments. Further, KH Ratthanathibeth will be
upgraded to KH International Hospital by 3Q17 to attract premium
patients. It will transfer all SS services to KV Rathanathibeth in 2018 to
allow space for more cash patients.
Trading at lowest EV/EBITDA multiple in our Healthcare coverage
We revised down FY17-19F earnings by 9% to reflect lower-than-
expected EBITDA margin and soft trends in international patients at
WMC in 4Q16. We maintain OUTPERFORM but lower TP to Bt16.5/sh
from Bt18/sh. BCH offers 18% earnings growth (CAGR) over FY16-19F
while trading at only 18x FY17F EV/EBITDA vs peers average of 21x. YTD 1Mth 3Mth 12Mth
Upside risks include higher fixed payment and compensation rates for Absolute (%) (11.5) (7.7) (8.4) 22.4
SS patients, which SSO may announce this year. Relative to index (%) (11.3) (4.9) (9.0) 11.9

Financial Summary (Btm)

Krungsri Securities vs Market
Year to Dec 2015 2016 2017F 2018F 2019F
Positive Neutral Negative
Sales (Btm) 5,766 6,511 7,218 8,124 9,097 Market
Growth (%) 9 13 11 13 12 Recommend 13 2 1
EBITDA (Btm) 1,459 1,805 2,042 2,311 2,600 Krungsri Market % +/-
Growth (%) 3 24 13 13 12 Target Price (Bt) 16.5 16.1 2.2
17 Net Profit (Btm) 902 919 (1.9)
Recurring profit (Btm) 527 753 902 1,059 1,242
18 Net Profit (Btm) 1,059 1,081 (2.0)
Growth (%) 1 43 20 17 17
Net profit (Btm) 527 753 902 1,059 1,242 Krungsri's earnings revision
FDEPS (Bt) (Core) 0.21 0.30 0.36 0.42 0.50 2017F 2018F
Growth (%) 1 43 20 17 17 Earnings revision (%) (8.9) (8.9)
PE (x) 61.9 43.4 36.2 30.8 26.3 Source: Bloomberg, Krungsri Securities
DPS (Bt) 0.12 0.17 0.22 0.25 0.30
Yield (%) 0.9 1.3 1.7 1.9 2.3
BVPS (Bt) 1.75 1.91 2.11 2.31 2.56
P/BV (x) 7.5 6.9 6.2 5.7 5.1
Disclaimer: This publication constitutes information disclosed to the public and believed to be reliable but its accuracy and completeness are not guaranteed. All opinions,
suggestions, or projections are for informational purposes only and shall not be construed as an inducement for the sale or purchase of securities. Amendments to this
publication may be made without prior notice. Investors are urged to exercise caution in making a decision to invest in any securities.
1
Company Update | BCH March 20, 2017

The best job in Thailand campaign: recruiting a surveyor of Social Security: Free health checks for members starting
patient happiness at WMC for a salary of Bt1.0m/month for 2017
6-month periods

Source: Company Data, www.theworldmedicalcenter.com Source: www.matichon.co.th, SSO

Healthcare: EV/EBITDA Healthcare: EBITDA margin

x %
26.0 24.8 35.0

24.0 31.4 31.6

21.9 30.0
22.0 21.1 28.3 28.4
20.7 27.6
20.3 20.2 26.8 26.2
20.0 25.0
18.6 18.2 25.0
17.7 17.9 17.9
18.0 21.3
21.0 20.7
15.7 20.1
16.0 20.0

14.0
15.0
12.0

10.0
10.0
CHG LPH VIBHA BH BDMS BCH
BH BCH VIBHA CHG BDMS LPH
2017 2018
2017 2018

Source: Krungsri Securities Source: Krungsri Securities

BCH: Revised assumptions

FY17F Chg FY18F Chg FY19F Chg
old new old new old new
BCH - Revenue (Btm) 7,316 7,218 -1.3% 8,273 8,124 -1.8% 9,240 9,097 -1.5%
BCH - EBITDA margin (%) 29.7% 28.3% -1.4% 29.6% 28.4% -1.2% 30.0% 28.6% -1.4%
BCH - Earnings (Btm) 991 902 -8.9% 1,162 1,059 -8.9% 1,358 1,242 -8.5%
Source: Krungsri Securities

Krungsri Securities Research 2

Company Update | BCH March 20, 2017

BCH: Hospitals
Opening/
No Hospitals Target customers OPD-rooms License beds
Acquiring year
1 World Medical Center Hospital high-end 2013 84 150
2 Kasemrad Bangkae 1984 54 311
3 Kasemrad Prachachuen 1997 55 373
4 Kasemrad Rattanatibeth middle-income / 1993 41 400
5 Kasemrad Saraburi social security 1996 14 200
6 Kasemrad Sriburin 1993 36 120
7 Kasemrad Chaseongsao 2015 16 100
8 Karunvej Sukhapibal 3 2000 16 100
9 Karunvej Pathum Thani Hospital 2013 17 200
social security
10 Karunvej Ayudhaya Hospital 2013 9 105
11 Karunvej Rattanatibeth 2015 18 119
Total 360 2,178
Source: Company data

BCH: Greenfield projects in the pipeline

Hospital Capex (Btm) Expected opening Capacity
Kasemrad Ramkhamhaeng 550 2Q18 139 beds
Kasemrad Chiang Khong 60 2Q18 30 beds
Kasemrad Aranyaprathet 350 4Q18 116 beds
Kasemrad Prachinburi 350 2019 115 beds
Kasemrad International Hospital Vientiane (BCH has 76% Stake) 1,000 2020 100 beds
Total 2,310 500 beds
Source: Company data

BCH: Expansion and renovation projects in the pipeline

Hospital Capex (Btm) Expected opening Capacity
Upgrade Kasemrad Chachoengsao 60 2Q17 +OPD, MRI, ER, Mammogram
Upgrade Kasemrad Rattanathibeth 50 2Q17 +ENT and renovation
Upgrade Kasemrad Sriburin 130 2Q17 + OPD, ICU, Heart Center
Upgrade Kasemrad Saraburi 50 3Q17 +Hemodialysis
Upgrade Maesai Clinic to Kasemrad Maesai Hospital 20 2Q17 +30 beds
Total 310
Source: Company data

BCH: Key assumptions

FY16A FY17F FY18F FY19F
SS Volume growth 14% 6% 7% 7%
SS revenue / patient growth 7% 3% 3% 3%
OPD Volume growth 6% 6% 10% 10%
OPD revenue / patient growth 1% 5% 4% 4%
IPD Volume growth 11% 8% 8% 6%
IPD revenue / patient growth 5% 5% 5% 5%

Capex (Btm) 780 1,100 860 460

GPM 31% 32% 33% 33%

SG&A/Sale 13% 13% 13% 13%
Source: Krungsri Securities

Krungsri Securities Research 3

Company Update | BCH March 20, 2017

P/E Band P/BV Band

Source: Bloomberg, Krungsri Securities Source: Bloomberg, Krungsri Securities

Peer table
Market PE P/BV EPS Div Yld ROE Share Price
Cap (x) (x) Growth% (%) (%) Performance
BB Ticker Name US$ 17F 18F 17F 18F 17F 18F 17F 17F 1M 3M 6M YTD
BCH TB BANGKOK CHAIN HOSPITAL PCL 937 36.2 30.8 6.2 5.7 0.2 0.2 1.7 18.0 (7.7) (8.4) 11.0 (11.5)
BH TB BUMRUNGRAD HOSPITAL PCL 3,773 32.9 29.3 7.8 6.8 0.1 0.1 1.6 25.4 (1.6) 0.6 5.2 (0.3)
BDMS TB BANGKOK DUSIT MED SERVICE 9,066 36.9 33.9 5.1 4.7 0.1 0.1 1.3 15.0 (1.9) (9.3) (10.1) (11.7)
CHG TB CHULARAT HOSPITAL PCL 776 40.1 34.3 7.9 7.0 0.2 0.2 1.2 20.6 (10.9) (14.0) (3.9) (14.0)
EKH TB EKACHAI MEDICAL CARE PCL 108 46.6 39.5 4.4 4.1 0.2 0.2 0.9 9.7 (7.4) (10.1) 6.8 (10.7)
LPH TB LADPRAO GENERAL HOSPITAL PCL 201 36.6 30.8 4.3 4.0 0.2 0.2 1.4 11.8 (6.0) 3.3 6.2 (3.1)
VIBHA TB VIBHAVADI MEDICAL CENTER PCL 1,125 47.5 37.5 5.7 5.0 0.2 0.3 1.3 12.3 1.4 4.2 N/A 2.1
RJH TB RAJTHANEE HOSPITAL PCL 194 34.5 30.2 4.1 3.9 85.3 14.1 1.5 12.3 (12.6) (12.6) N/A (11.8)
RHC AU RAMSAY HEALTH CARE LTD 10,133 24.8 22.1 6.0 5.4 17.6 11.8 2.1 24.7 (9.0) (2.6) (16.3) (4.5)
APHS IN APOLLO HOSPITALS ENTERPRISE 2,583 59.0 41.0 4.6 4.2 (8.4) 43.8 0.5 7.8 (4.3) 0.1 (6.8) 3.1
KPJ MK KPJ HEALTHCARE BERHAD 950 28.3 24.1 2.6 2.4 17.2 17.6 1.7 9.2 (0.5) (2.4) (4.3) (3.8)
RYM NZ RYMAN HEALTHCARE LTD 2,954 25.8 22.3 2.8 2.5 51.4 16.0 2.2 11.5 (3.4) 4.0 (10.5) 3.8
RFMD SP RAFFLES MEDICAL GROUP LTD 1,767 32.9 28.9 3.4 3.2 9.3 14.0 1.4 11.1 (4.4) (1.7) (8.1) (1.0)
IHH SP IHH HEALTHCARE BHD 11,164 44.9 36.5 0.7 0.7 0.0 0.0 0.6 4.7 (4.5) (7.8) (10.8) (11.2)
Average (Simple) 37.6 31.5 4.7 4.3 12.4 8.5 1.4 13.9
Source: Bloomberg, Krungsri Securities

Krungsri Securities Research 4

Company Update | BCH March 20, 2017

Financial statement - Quarterly (Btm) 4Q15 1Q16 2Q16 3Q16 4Q16

Sales 1,606 1,541 1,531 1,747 1,693

COGS (inc dep'n) (1,053) (1,062) (1,082) (1,163) (1,166)
Gross Profit 553 480 449 583 527
SG&A (257) (205) (189) (219) (222)
Operating Profit 296 274 260 364 305
Net other income 26 20 29 23 26
Net interest (41) (46) (48) (28) (39)
Pretax profit 281 248 241 358 292
Income Tax (51) (50) (44) (65) (49)
Associates 0 0 0 0 0
Minority interest (38) (43) (41) (50) (45)
Profit after tax (pre-ex) 192 156 156 243 198
Extraordinaries, GW & FX 0 0 0 0 0
Reported net profit 192 156 156 243 198

Shares out (end Q, m) 2,494 2,494 2,494 2,494 2,494

Adjusted shares (m) 2,494 2,494 2,494 2,494 2,494

Pre-ex EPS 0.08 0.06 0.06 0.10 0.08

EPS 0.08 0.06 0.06 0.10 0.08

Depreciation 127 124 126 134 132

EBITDA 449 418 415 520 463

Key ratios
Gross margin (%) 34% 31% 29% 33% 31%
SG&A/Revenue (%) 16% 13% 12% 13% 13%
EBITDA margin (%) 28% 27% 27% 30% 27%
Net profit margin (%) 12% 10% 10% 14% 12%

Krungsri Securities Research 5

Company Update | BCH March 20, 2017

INCOME STATEMENT (Btm) 2015 2016 2017F 2018F 2019F

Turnover 5,766 6,511 7,218 8,124 9,097
Cost of sales (COGS) (3,528) (3,958) (4,337) (4,869) (5,434)
Depreciation & amortization (461) (514) (542) (587) (628)
Gross profit 1,777 2,039 2,340 2,668 3,035
S&A expense (855) (835) (931) (1,040) (1,164)
Operating profit 922 1,204 1,409 1,628 1,871
Other operating income 76 87 91 96 101
EBIT 998 1,291 1,500 1,724 1,972
Interest expense (163) (162) (145) (136) (127)
Interest income 9 11 10 5 4
Other income 0 0 0 0 0
Goodwill amortization 0 0 0 0 0
Pre-tax profit 844 1,140 1,364 1,593 1,849
Income tax on company & subsidiaries (174) (208) (266) (319) (370)
Profit after tax 670 932 1,098 1,275 1,479
Minority interests (145) (180) (198) (217) (239)
Share of associate net income 3 1 2 2 2
Preferred dividends 0 0 0 0 0
Recurring attributable net profit 527 753 902 1,059 1,242
Extraordinary items 0 0 0 0 0
Reported net profit 527 753 902 1,059 1,242
Shares in issue (Y/E, m) 2,494 2,494 2,494 2,494 2,494
Shares in issue (weighted avg. m) 2,494 2,494 2,494 2,494 2,494
EPS (before extraordinary items, Bt) 0.21 0.30 0.36 0.42 0.50
DPS (Bt) 0.12 0.17 0.22 0.25 0.30
DPS/EPS (%) 57 56 60 60 60

CASH FLOW (Btm) 2015 2016 2017F 2018F 2019F

Operating profit 922 1,204 1,409 1,628 1,871
Other operating income 76 87 91 96 101
EBIT 998 1,291 1,500 1,724 1,972
Depreciation & amortization 461 514 542 587 628
EBITDA 1,459 1,805 2,042 2,311 2,600
Notional cash taxes on ungeared operations (222) (255) (308) (359) (407)
Net change in working capital (10) 86 80 105 113
CAPEX (757) (692) (1,496) (856) (456)
Operating free cashflow (OpFCF) 470 944 317 1,201 1,849
Net interest income adjusted for tax impact (112) (107) (97) (95) (89)
Net free cashflow (NetFCF) 358 837 219 1,107 1,760
Non-operating income (net of tax) 0 0 0 0 0
Equity income from associates 3 1 2 2 2
Investments 20 20 0 (0) (0)
Net change in other assets/liabilities 46 13 0 0 0
Other items (22) 132 0 0 0
Residual cashflow (RCF) 405 1,004 221 1,109 1,762
Dividends (440) (504) (424) (541) (635)
Equity capital raised (0) (0) (0) (0) (0)
Other items (119) (166) (105) (130) (143)
Cashflow from financing (558) (671) (529) (672) (779)
Net change in cash (153) 334 (307) 437 983
Net cash/(debt) at YS (3,594) (3,747) (3,414) (3,721) (3,284)
Ending net cash /(debt) (3,747) (3,414) (3,721) (3,284) (2,301)
Increase/(decrease) in cash & equivalents 194 (126) (322) (63) 983
(Increase)/decrease in debt (347) 460 16 500 0
NOPLAT (net op profit less adjusted tax) 776 1,035 1,192 1,365 1,564
Normalized OpFCF (Est maint CAPEX) 522 886 1,413 1,658 1,905
FCFE (free cashflow to equity) 752 545 206 609 1,762

Krungsri Securities Research 6

Company Update | BCH March 20, 2017

BALANCE SHEET (Btm) 2015 2016 2017F 2018F 2019F

Cash & equivalents 806 680 358 295 1,277
A/C receivable 1,077 997 997 997 997
Inventory 189 195 214 240 268
Others 64 65 72 81 90
Total Current Assets 2,137 1,937 1,640 1,612 2,632
Property and equipment 7,859 8,039 8,998 9,271 9,103
Investments & associates 69 49 49 49 49
Other assets 82 73 73 73 73
Goodwill 451 471 471 471 471
Total Assets 10,598 10,569 11,231 11,476 12,329
Short-term debt 2,028 1,596 1,080 80 1,080
A/C payable 409 456 500 562 627
Other current liabilities 605 569 631 710 795
Total Current Liabilities 3,042 2,621 2,211 1,352 2,502
Long-term debt 2,526 2,498 2,999 3,499 2,499
Other liabilities 108 113 113 113 113
Total Liabilities 5,676 5,233 5,323 4,963 5,114
Share capital 2,494 2,494 2,494 2,494 2,494
Share premium 645 645 645 645 645
Revaluation surplus (15) (14) 0 0 0
Translation adjustment 0 0 0 0 0
Retained earnings 1,235 1,636 2,115 2,633 3,239
Total ordinary equity 4,359 4,761 5,253 5,771 6,377
Preferred equity 0 0 0 0 0
Minorities 563 576 655 742 837
Total equity & minorities 4,922 5,337 5,908 6,513 7,215
Accumulated depreciation 3,881 3,883 4,425 5,012 5,640
BV per ordinary share (Y/E, Bt) 1.75 1.91 2.11 2.31 2.56
Adjusted book value ps (Y/E, Bt) 1.75 1.91 2.11 2.31 2.56

RATIOS (%) 2015 2016 2017F 2018F 2019F

Growth
Turnover 8.8 12.9 10.9 12.5 12.0
EBITDA 2.5 23.7 13.1 13.2 12.5
EBIT 0.8 29.3 16.2 14.9 14.4
Net profit 1.0 42.8 19.8 17.4 17.3
EPS pre extraordinary items 1.0 42.8 19.8 17.4 17.3
EPS (diluted) 1.0 42.8 19.8 17.4 17.3
DPS (29.4) 41.7 27.7 17.4 17.3
Accounting ratios
Cash profit margin 38.8 39.2 39.9 40.1 40.3
Gross profit margin 30.8 31.3 32.4 32.8 33.4
Operating profit margin 16.0 18.5 19.5 20.0 20.6
Net profit margin 9.1 11.6 12.5 13.0 13.7
Turnover/avg total assets (x) 0.6 0.6 0.7 0.7 0.8
ROA 5.1 7.1 8.3 9.3 10.4
ROE 12.4 16.5 18.0 19.2 20.4
S&A/turnover 14.8 12.8 12.9 12.8 12.8
Effective tax rate 20.6 18.3 19.5 20.0 20.0
Operating performance
EBITDA margin 25.3 27.7 28.3 28.4 28.6
EBIT margin 17.3 19.8 20.8 21.2 21.7
NOPLAT margin (NOPLAT/Turnover) 13.5 15.9 16.5 16.8 17.2
Asset turnover (Turnover/avg Op assets) 0.7 0.8 0.8 0.9 1.0
ROCE (NOPLAT/avg Op assets) 9.7 12.5 13.6 14.7 17.0
ROCE inc capitalised goodwill 9.2 11.9 12.9 14.0 16.1

Krungsri Securities Research 7

Company Update | BCH March 20, 2017

EQUITY VALUATIONS (Bt) 2015 2016 2017F 2018F 2019F

EPS 0.21 0.30 0.36 0.42 0.50
FDEPS 0.21 0.30 0.36 0.42 0.50
FDEPS growth (%) 1.05 42.81 19.83 17.36 17.26
DPS 0.12 0.17 0.22 0.25 0.30
BVPS 1.75 1.91 2.11 2.31 2.56
Adjusted BVPS 1.75 1.91 2.11 2.31 2.56
Free cashflow to equity (FCFE) per share 0.30 0.22 0.08 0.24 0.71
Share price (Bt) 13.1
PE (x) 61.9 43.4 36.2 30.8 26.3
PE (fully diluted, x) 61.9 43.4 36.2 30.8 26.3
PE/FDEPS growth (x) 59.2 1.0 1.8 1.8 1.5
Yield (%) 0.9 1.3 1.7 1.9 2.3
P/BV (x) 7.5 6.9 6.2 5.7 5.1
P/ABV (x) 7.5 6.9 6.2 5.7 5.1
P/FCFE (x) 43.4 60.0 158.7 53.7 18.5

ENTERPRISE VALUATIONS (Btm) 2015 2016 2017F 2018F 2019F

Ordinary shares (m) 2,494 2,494 2,494 2,494 2,494
Share price (Bt) 9 15 13 13 13
Ordinary equity MV 22,568 36,907 32,668 32,668 32,668
MI & deferred taxes 563 576 655 742 837
Equity MV (adjusted ord) 23,131 37,483 33,323 33,410 33,506
Preferred equity 0 0 0 0 0
Debt 4,554 4,094 4,079 3,579 3,579
Enterprise Value 27,685 41,577 37,402 36,988 37,084
Net noncore assets 1,269 1,136 806 734 1,707
Core Enterprise Value (EV) 26,417 40,442 36,595 36,255 35,377
Turnover 5,766 6,511 7,218 8,124 9,097
EBITDA 1,459 1,805 2,042 2,311 2,600
EBIT 998 1,291 1,500 1,724 1,972
NOPLAT 776 1,035 1,192 1,365 1,564
OpFCF 470 944 317 1,201 1,849
OpFCF (normalized) 522 886 1,413 1,658 1,905
Op (core) capital employed (CE) 8,207 8,295 9,181 9,358 9,087
Avg. core capital employed 8,045 8,251 8,738 9,269 9,222
Core EV Multiples
EV/Turnover (x) 4.6 6.2 5.1 4.5 3.9
EV/EBITDA (x) 18.1 22.4 17.9 15.7 13.6
EV/EBIT (x) 26.5 31.3 24.4 21.0 17.9
EV/NOPLAT (x) 34.0 39.1 30.7 26.6 22.6
EV/OpFCF (x) 56.2 42.8 115.5 30.2 19.1
EV/OpFCFnormalised (x) 50.6 45.6 25.9 21.9 18.6
EV/capital employed (YE, x) 3.2 4.9 4.0 3.9 3.9
EV/avg capital employed (x) 3.3 4.9 4.2 3.9 3.8

RISK MEASURES 2015 2016 2017F 2018F 2019F

Equity multiplier (avg. total assets/avg. equity) 2.4 2.3 2.2 2.1 2.0
Net debt/equity & MI 0.8 0.6 0.6 0.5 0.3
Interest cover (x)
Interest cover (EBIT & int.incl/int. expense) 6.2 8.0 10.4 12.7 15.6
NOPLAT/interest paid 4.6 6.3 8.0 9.8 12.0
Debt service (OpFCF/net interest paid) 2.9 6.1 2.3 8.9 14.6
Short-Term Ratios (x)
Current assets/current liabilities 0.7 0.7 0.7 1.2 1.1
Current assets less inventory/current liabilities 0.6 0.7 0.6 1.0 0.9
A/C receivable, days turnover 68.2 55.9 50.4 44.8 40.0
Inventory, days COGS 19.6 18.0 18.0 18.0 18.0
A/C payable, days COGS 42.3 42.1 42.1 42.1 42.1

Krungsri Securities Research 8

CG Rating 2015 Companies with CG Rating

ADVANC BAFS BCP BIGC BTS CK CPN DRT DTAC DTC EASTW EGCO GRAMMY HANA
HMPRO INTUCH IRPC IVL KBANK KCE KKP KTB LHBANK LPN MCOT MINT MONO NKI
PHOL PPS PS PSL PTT PTTEP PTTGC QTC RATCH ROBINS SAMART SAMTEL SAT SC
SCB SCC SE-ED SIM SNC SPALI THCOM TISCO TKT TMB TOP VGI WACOAL

AAV ACAP AGE AHC AKP AMATA ANAN AOT APCS ARIP ASIMAR ASK ASP BANPU
BAY BBL BDMS BKI BLA BOL BROOK BWG CENTEL CFRESH CHO CIMBT CM CNT
COL CPF CPI CSL DCC DELTA DEMCO ECF EE ERW GBX GC GFPT GLOBAL
GUNKUL HOTPOT HYDRO ICC ICHI INET IRC KSL KTC LANNA LH LOXLEY LRH MACO
MBK MC MEGA MFEC NBC NCH NINE NSI NTV OCC OGC OISHI OTO PAP
PDI PE PG PJW PM PPP PR PRANDA PREB PT PTG Q-CON QH RS
S&J SABINA SAMCO SCG SEAFCO SFP SIAM SINGER SIS SITHAI SMK SMPC SMT SNP
SPI SSF SSI SSSC SST STA STEC SVI SWC SYMC SYNTEC TASCO TBSP TCAP
TF TGCI THAI THANA THANI THIP THRE THREL TICON TIP TIPCO TK TKS TMI
TMILL TMT TNDT TNITY TNL TOG TPC TPCORP TRC TRU TRUE TSC TSTE TSTH
TTA TTCL TTW TU TVD TVO UAC UT UV VNT WAVE WINNER YUASA ZMICO

2S AEC AEONTS AF AH AIRA AIT AJ AKR AMANAH AMARIN AP APCO AQUA

AS ASIA AUCT AYUD BA BEAUTY BEC BFIT BH BIG BJC BJCHI BKD BTNC
CBG CGD CHG CHOW CI CITY CKP CNS CPALL CPL CSC CSP CSS CTW
DNA EARTH EASON ECL EFORL ESSO FE FIRE FOCUS FORTH FPI FSMART FSS FVC
GCAP GENCO GL GLAND GLOW GOLD GYT HTC HTECH IEC IFEC IFS IHL IRCP
ITD JSP JTS JUBILE KASET KBS KCAR KGI KKC KTIS KWC KYE L&E LALIN
LHK LIT LST M MAJOR MAKRO MATCH MATI MBKET M-CHAI MFC MILL MJD MK
MODERN MOONG MPG MSC MTI MTLS NC NOK NUSA NWR NYT OCEAN PACE PATO
PB PCA PCSGH PDG PF PICO PL PLANB PLAT PPM PRG PRIN PSTC PTL
PYLON QLT RCI RCL RICHY RML RPC S SALEE SAPPE SAWAD SCCC SCN SCP
SEAOIL SIRI SKR SMG SOLAR SORKON SPA SPC SPCG SPPT SPVI SRICHA SSC STANLY
STPI SUC SUSCO SUTHA SYNEX TAE TAKUNI TCC TCCC TCJ TEAM TFD TFI TIC
TIW TLUXE TMC TMD TOPP TPCH TPIPL TRT TSE TSR TT UMI UP UPF
UPOIC UREKA UWC VIBHA VIH VPO WHA WIN XO

Disclaimer
The disclosure of the survey result of the Thai Institute of Directors Association ("IOD") regarding corporate governance is made pursuant to
the policy of the Office of the Securities and Exchange Commission. The survey of the IOD is based on the information of a company listed on
the Stock Exchange of Thailand and the Market for Alternative Investment disclosed to the public and able to be accessed by a general public
investor. The result, therefore, is from the perspective of a third party. It is not an assessment of operation and is not based on inside
information. The survey result is as of the date appearing in the Corporate Governance Report of Thai Listed Companies. As a result, the
survey result may be changed after that date or when there is any change to the relevant information. Nevertheless, Krungsri Securities Public
Company Limited does not confirm, verify, or certify the accuracy and completeness of such survey result.
Anti-corruption Progress Indicator 2015
Level 5: Extended
BCP CPN GYT PE PM PPP PT PTT PTTGC SAT SCC THANI TOP

Level 4: Certified
ADVANC AMANAH ASP AYUD BAFS BANPU BAY BBL BKI BLA BTS CFRESH CIMBT CNS
CSL DCC DRT DTC EASTW ECL EGCO ERW FSS GCAP HANA HTC IFEC INTUCH
IRPC IVL KBANK KCE KGI KKP KTB LANNA LHBANK MBKET MFC MINT MTI NKI
PPS PSL PTG PTTEP SABINA SCB SINGER SIS SNC SNP SSF SSI SSSC SVI
TCAP THCOM THRE THREL TISCO TMB TMD TNITY TOG TSTH

Level 3B: Established by Commitment and Policy

AAV AHC AIT AKR ARROW ASK BA BDMS BEC BJCHI CGH CHG CHOW CIG
CITY CK CKP COLOR CWT EARTH EASON EPG F&D FANCY FIRE FMT FORTH GENCO
GL GOLD GPSC GRAMMY HYDRO IRCP IT JCT KCM KWC LH LIT LOXLEY MACO
MANRIN MATI MODERN MSC NOBLE NOK NPK NUSA OISHI OTO PAF PAP PATO PF
PJW PLANB PLE POLAR PRG PTL Q-CON QTC RCI S11 SALEE SAM SAMART SAMTEL
SAPPE SC SCP SFP SIM SLP SMT SPA SPORT SSC SST STEC STPI SUC
SUTHA T TAE TBSP TCC TFD TGCI TGPRO THANA THIP TIW TK TMW TNDT
TOPP TPC TPCH TPIPL TSR TT TYCN UAC UBIS UEC UMI UP UPF UT
UV VPO WAVE WINNER YUASA

Level 3A: Established by declaration of intent

ABC ACAP AGE AH ANAN AP APCS APURE AS ASIA ASIAN ASIMAR BIGC BROOK
BWG CEN CENTEL CHARAN CHO CHOTI CM CNT COL CPF CPI CPL DELTA DEMCO
DIMET DNA DTAC EA ECF EE EVER FPI GBX GC GFPT GLOW HMPRO HOTPOT
ICC ICHI INOX INSURE IRC JAS JTS JUBILE KC KTC KYE LHK LPN LRH
MAKRO MC MCOT MFEC MJD MONO MOONG NBC NDR NINE NMG NSI NTV OGC
PACE PCSGH PDI PG PHOL PLAT PR PRANDA PREB PS QLT RATCH RML ROBINS
ROJNA RWI SAMCO SCCC SCG SEAOIL SE-ED SENA SITHAI SMK SMPC SPALI SPC SPCG
SPI SRICHA STANLY SUPER SYMC SYNEX SYNTEC TASCO TCMC TFI THAI TICON TKT TLUXE
TMILL TMT TNL TPCORP TSTE TTCL TU TVI UOBKH UREKA VGI VNT WACOAL WHA
ZMICO

Level 2: Declared
2S ABICO AF AIRA AKP ALUCON AMARIN AMATA AOT APCO BEAUTY BFIT BH BKD
BLAND BROCK BRR BSBM BTNC CCP CI CSC CSR CSS EFORL EPCO ESTAR FE
FER FNS FVC GEL GLOBAL GUNKUL IEC IFS ILINK INET J JMT JUTHA K
KASET KBS KCAR KKC KSL KTECH L&E LALIN LTX M MALEE MBAX MBK MEGA
MILL MK MPG MTLS NCH NCL NNCL NPP OCC OCEAN PB PCA PDG PRINC
PSTC PYLON QH ROCK ROH RP RPC S&J SGP SIAM SKR SMG SMIT SORKON
SPACK SPPT SR SUSCO TAKUNI TEAM TF TIC TIP TIPCO TMC TMI TPA TPP
TRT TRU TRUE TSC TSI TTW TVD TVO TVT U UKEM UNIQ UWC VIBHA
VNG WIIK WIN XO

Level 1: Committed
AEONTS AFC AJ AMC AQUA ARIP AUCT BAT-3K BIG BJC BOL CBG CCET CCN
CGD CMR CPH CSP CTW DCON DRACO DSGT DTCI E EMC ESSO FOCUS FSMART
GIFT GLAND GRAND GREEN HFT HTECH IHL ITD JSP KDH KTIS KTP LEE LST
MAJOR MATCH MAX M-CHAI MDX MIDA ML MPIC NC NEP NWR OHTL PICO PK
PL PPM PRAKIT PRECHA PRIN RAM RICH RS SANKO SAUCE SAWAD SAWANG SCN SEAFCO
SF SHANG SIRI SMART SMM SOLAR SPG SPVI STA STAR SVH SVOA SWC TAPAC
TC TCCC TCJ TCOAT TH TKS TNH TNPC TPAC TPOLY TRC TRUBB TSE TTA
TTI TTL TTTM TWP TWZ UMS UPA UPOIC UTP UVAN VARO VI VIH VTE
WG

Disclaimer
The disclosure of the Anti-Corruption Progress Indicators of a listed company on the Stock Exchange of Thailand, which is assessed by
Thaipat Institute, is made in order to comply with the policy and sustainable development plan for the listed companies of the Office of the
Securities and Exchange Commission. Thaipat Institute made this assessment based on the information received from the listed company, as
stipulated in the form for the assessment of Anti-corruption which refers to the Annual Registration Statement (Form 56-1), Annual Report
(Form 56-2), or other relevant documents or reports of such listed company . The assessment result is therefore made from the perspective of
Thaipat Institute that is a third party. It is not an assessment of operation and is not based on any inside information. Since this assessment is
only the assessment result as of the date appearing in the assessment result, it may be changed after that date or when there is any change
to the relevant information. Nevertheless, Krungsri Securities Public Company Limited does not confirm, verify, or certify the accuracy and
completeness of the assessment result."

Reference
Level 5: Extended Extension of the anti-corruption policy to business partners in the supply chain, and disclosure of any current
investigations, prosecutions or closed cases
Level 4: Certified Audit engagement by audit committee or auditors approved by the office of SEC, and receiving certification or assurance
by independent external assurance providers (CAC etc.)
Level 3: Established Carrying out preventive measures, risk assessment, communication and training for all employees, including
consistent monitoring and review processes
Level 3A: Established by declaration of intent, Level 3B: Established by Commitment and Policy
Level 2: Declared Public declaration statement to participate in Thailand's private sector Collective Action Coalition Against Corruption
(CAC) or equivalent initiatives
Level 1: Committed Organizations statement or board's resolution to work against corruption and to be in compliance with all relevant laws
 Krungsri Securities Public Company Limited
Headquarters
898 Ploenchit Tower, 3rd Floor, Ploenchit Road, Lumpini
Pathumwan, Bangkok 10330
Tel: 0-2659-7000 Fax: 0-2658-5699
Internet Trading: 0-2659-7777
Branches
Emporium Nakhon Pathom
662 Emporium Tower, Fl. 10, Sukhumvit 24 Road 67/1 Ratchadamnoen Road, Tambol Phra Pathom Jaedee,
Klongton, Klongtoey, Bangkok 10110 Amphur Muang, Nakhon Pathom 73000
Tel: 0-2695-4500 Fax: 0-2695-4599 Tel: 0-3427-5500-7 Fax: 0-3421-8989
Central Bangna Suphanburi
589/151 Central City Tower 1 Office, Fl. 27 249/171-172 Moo 5 Tambol Ta Rahad,
Bangna-Trad Road, Bangna, Bangkok 10260 Amphur Muang, Suphanburi, 72000
Tel: 0-2763-2000 Fax: 0-2399-1448 Tel: 0-3550-1234 Fax: 0-3552-2449
Rama II Nakhon Ratchasima
111/917-919 Rama II Road, Smaedum, 168 Chomphon Road, Tambol Nai Muang,
Bangkhuntien, Bangkok 10150 Amphur Muang Nakhon Ratchasima,
Tel: 0-2895-9575 Fax: 0-2895-9557 Nakhon Ratchasima 30000
Tel: 0-4425-1211-4 Fax: 0-4425-1215
Vibhavadi-rangsit
Bank of Ayudhya Public Company Limited Khon Kaen
123 Suntowers (B) Building, Vibhavadirangsit Road, 114 Sri Chan Road, Tambol Nai Muang,
Jompol, Jatujak, Bangkok 10900 Amphur Muang, Khon Kaen 40000
Tel: 0-2273-8388 Fax: 0-2273-8399 Tel: 0-4322-6120 Fax: 0-4322-6180
Chonburi Chiang Mai
64/17 Sukhumvit Road, Tambol Bang Plasoi, 70 Chang Phuak Road, Tambol Sri Phum
Amphur Muang, Chonburi 20000 Amphur Muang, Chiang Mai 50200
Tel: 0-3879-0430 Fax: 0-3879-0425 Tel: 0-5321-9234-6 Fax: 0-5321-9247
Hat Yai Branch Chiang Rai
90-92-94 Nipat U Tit Nueng Road,Tambol Hat Yai, 231-232 Thamalai Road, Tambol Wiang,
Amphur Hat Yai, Songkhla 90110 Amphur Muang, Chiang Rai 57000
Tel: 0-7422-1229 Fax: 0-7422-1411 Tel: 0-5371-6489 Fax: 0-5371-6490
Phitsanulok
275/1 Phichaisongkram Road, Tambol Nai Muang,
Amphur Muang, Phitsanulok 65000
Tel: 0-5530-3360 Fax: 0-5530-2580
Central line:
Analyst Team Sector Coverage 662-659-7000 E-mail

Naphat Chantaraserekul, Head of Research Energy, Petrochemical, Strategy ext. 5000 naphat.chantaraserekul@krungsrisecurities.com
Kittisorn Pruitipat, CFA, FRM Construction
Property, ICT,Materials
Contractor ext. 5019 kittisorn.pruitipat@krungsrisecurities.com
Jesada Techahusdin, CFA Banking, Consumer Finance, Insurance ext. 5004 jesada.techahusdin@krungsrisecurities.com
Sunthorn Thongthip Insurance
Food, Insurance Strategy
Transportation, ext. 5009 sunthorn.thongthip@Krungsrisecurities.com
Worrapong Tuntiwutthipong Electronic, Automotive, Commerce ext. 5016 worrapong.tuntiwutthipong@krungsrisecurities.com
Karun Intrachai Media
Renewable Energy ext. 5010 karun.intrachai@krungsrisecurities.com
Teerapol Udomvej Healthcare, Tourism ext. 5012 teerapol.udomvej@krungsrisecurities.com
Kitti Pitakteerabandit, Assistant Analyst
Artit Jansawang Mid - Small cap, MAI ext. 5005 artit.jansawang@krungsrisecurities.com
Nalinee Praman, Assistant Analyst Mid - Small cap, MAI

Fax 662-658-5643
Definition of Ratings
OUTPERFORM - Stocks with an expected capital gain above 10% in the next 12 months for small-caps, above 5% for big-caps
NEUTRAL - Stocks with an expected capital gain between -10% and +10% in the next 12 months for small-caps, -5% to +5% for big-caps
UNDERPERFORM - Stocks with an expected capital gain below 10% in the next 12 months for small-caps, below 5% for big-caps
www.krungsrisecurities.com